Elizabeth Shpall

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Couriel Daniel R; Saliba Rima; de Lima Marcos; Giralt Sergio; Andersson Borje; Khouri Issa; Hosing Chitra; Ippoliti Cindy; Shpall Elizabeth J; Champlin Richard; Alousi Amin
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.
Ciurea Stefan O; de Lima Marcos; Cano Pedro; Korbling Martin; Giralt Sergio; Shpall Elizabeth J; Wang Xuemei; Thall Peter F; Champlin Richard E; Fernandez-Vina Marcelo
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.
Parmar Simrit; Del Lima Marcos; Zou Yizhou; Patah Poliana A; Liu Ping; Cano Pedro; Rondon Gabriela; Pesoa Susana; de Padua Silva Leandro; Qazilbash Muzaffar H; Hosing Chitra; Popat Uday; Kebriaei Partow; Shpall Elizabeth J; Giralt Sergio; Champlin Richard E; Stastny Peter; Fernandez-Vina Marcelo
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Elizabeth Shpall (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Couriel Daniel R; Saliba Rima; de Lima Marcos; Giralt Sergio; Andersson Borje; Khouri Issa; Hosing Chitra; Ippoliti Cindy; Shpall Elizabeth J; Champlin Richard; Alousi Amin
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1555-62.
2009: Ciurea Stefan O; de Lima Marcos; Cano Pedro; Korbling Martin; Giralt Sergio; Shpall Elizabeth J; Wang Xuemei; Thall Peter F; Champlin Richard E; Fernandez-Vina Marcelo
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.
Transplantation 2009;88(8):1019-24.
2009: Parmar Simrit; Del Lima Marcos; Zou Yizhou; Patah Poliana A; Liu Ping; Cano Pedro; Rondon Gabriela; Pesoa Susana; de Padua Silva Leandro; Qazilbash Muzaffar H; Hosing Chitra; Popat Uday; Kebriaei Partow; Shpall Elizabeth J; Giralt Sergio; Champlin Richard E; Stastny Peter; Fernandez-Vina Marcelo
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
Blood 2009;114(14):2884-7.
2009: Shah Nina; Shpall Elizabeth J
NK antibody therapy: KIR-ative intent.
Blood 2009;114(13):2567-8.
2009: Steiner David; Gelovani Juri; Savoldo Barbara; Robinson Simon N; Decker William K; Brouard Nathalie; Najjar Amer; Xing Dongxia; Yang Hong; Li Sufang; Marini Frank; Zweidler-McKay Patrick A; Bollard Catherine M; Shpall Elizabeth J; Dotti Gianpietro; Simmons Paul J
Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cells.
Stem cells (Dayton, Ohio) 2009;27(8):1932-40.
2009: Hanley Patrick J; Cruz Conrad Russell Young; Savoldo Barbara; Leen Ann M; Stanojevic Maja; Khalil Mariam; Decker William; Molldrem Jeffrey J; Liu Hao; Gee Adrian P; Rooney Cliona M; Heslop Helen E; Dotti Gianpietro; Brenner Malcolm K; Shpall Elizabeth J; Bollard Catherine M
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.
Blood 2009;114(9):1958-67.
2009: Dotti Gianpietro; Tian Mei; Savoldo Barbara; Najjar Amer; Cooper Laurence J N; Jackson James; Smith Amanda; Mawlawi Osama; Uthamanthil Rajesh; Borne Agatha; Brammer David; Paolillo Vincenzo; Alauddin Mian; Gonzalez Carlos; Steiner David; Decker William K; Marini Frank; Kornblau Steven; Bollard Catherine M; Shpall Elizabeth J; Gelovani Juri G
Repetitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU.
Molecular imaging : official journal of the Society for Molecular Imaging 2009;8(4):230-7.
2009: Martin Paul J; Bachier Carlos R; Klingemann Hans-Georg; McCarthy Philip L; Szabolcs Paul; Uberti Joseph P; Schuster Michael W; Weisdorf Daniel; Chao Nelson J; Kebriaei Partow; Shpall Elizabeth J; Macmillan Margaret L; Soiffer Robert J
Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(7):777-84.
2009: Popat Uday; Saliba Rima; Thandi Rupinderjit; Hosing Chitra; Qazilbash Muzaffar; Anderlini Paolo; Shpall Elizabeth; McMannis John; Körbling Martin; Alousi Amin; Andersson Borje; Nieto Yago; Kebriaei Partow; Khouri Issa; de Lima Marcos; Weber Donna; Thomas Sheeba; Wang Michael; Jones Roy; Champlin Richard; Giralt Sergio
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):718-23.
2009: Jabbour Elias; Giralt Sergio; Kantarjian Hagop; Garcia-Manero Guillermo; Jagasia Madan; Kebriaei Partow; de Padua Leandro; Shpall Elizabeth J; Champlin Richard; de Lima Marcos
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.
Cancer 2009;115(9):1899-905.
2009: Decker William K; Xing Dongxia; Li Sufang; Robinson Simon N; Yang Hong; Steiner David; Komanduri Krishna V; Shpall Elizabeth J
Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens.
Blood 2009;113(18):4213-23.
2009: Nieto Yago; Shpall Elizabeth J
High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted?
Current opinion in oncology 2009;21(2):150-7.
2009: Safdar Amar; Decker William K; Li Sufang; Xing Dongxia; Robinson Simon N; Yang Hong; Steiner David; Rodriguez Gilhen; Shpall Elizabeth J; Bollard Catherine
De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination.
Vaccine 2009;27(10):1479-84.
2009: Ramos Carlos A; Saliba Rima M; de Pádua Leandro; Khorshid Ola; Shpall Elizabeth J; Giralt Sergio; Patah Poliana A; Hosing Chitra M; Popat Uday R; Rondon Gabriela; Khouri Issa F; Nieto Yago L; Champlin Richard E; de Lima Marcos
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Haematologica 2009;94(2):249-57.
2009: Champlin Richard; de Lima Marcos; Kebriaei Partow; Rondon Gabriela; Fisher Tobi; Jabbour Elias; Cortés Jorge E; Kantarjian Hagop; Anderlini Paolo; Alousi Amin; Hosing Chitra; Shpall Elizabeth; Popat Uday; Qazilbash Muzaffar; Andersson Borje; Giralt Sergio
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.
Clinical lymphoma & myeloma 2009;9 Suppl 3():S261-5.
2008: Ni Xiao; Richmond Heather M; Liao Xingsheng M; Decker William K; Shiue Lisa H; Shpall Elizabeth J; Duvic Madeleine
Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA.
The Journal of investigative dermatology 2008;128(11):2631-9.
2008: Rondón Gabriela; Saliba Rima M; Khouri Issa; Giralt Sergio; Chan Kawah; Jabbour Elias; McMannis John; Champlin Richard; Shpall Elizabeth
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):859-66.
2008: Andersson Borje S; de Lima Marcos; Thall Peter F; Wang Xuemei; Couriel Daniel; Korbling Martin; Roberson Soonja; Giralt Sergio; Pierre Betty; Russell James A; Shpall Elizabeth J; Jones Roy B; Champlin Richard E
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):672-84.
2008: de Lima M; McMannis J; Gee A; Komanduri K; Couriel D; Andersson B S; Hosing C; Khouri I; Jones R; Champlin R; Karandish S; Sadeghi T; Peled T; Grynspan F; Daniely Y; Nagler A; Shpall E J
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
Bone marrow transplantation 2008;41(9):771-8.
2008: Singh Harjeet; Manuri Pallavi R; Olivares Simon; Dara Navid; Dawson Margaret J; Huls Helen; Hackett Perry B; Kohn Donald B; Shpall Elizabeth J; Champlin Richard E; Cooper Laurence J N
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.
Cancer research 2008;68(8):2961-71.
2008: Decker William K; Shpall Elizabeth J
Progress in dendritic cell immunotherapy: elucidating the enigma of Th-1 polarization.
Human vaccines 2008;4(2):162-4.
2008: Decker William K; Li Sufang; Xing Dongxia; Robinson Simon N; Yang Hong; Steiner David; Komanduri Krishna V; Bollard Catherine M; Shpall Elizabeth J
Deficient T(H)-1 responses from TNF-alpha-matured and alpha-CD40-matured dendritic cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(2):157-65.
2008: de Lima M; Champlin R E; Thall P F; Wang X; Martin T G; Cook J D; McCormick G; Qazilbash M; Kebriaei P; Couriel D; Shpall E J; Khouri I; Anderlini P; Hosing C; Chan K W; Andersson B S; Patah P A; Caldera Z; Jabbour E; Giralt S
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(2):258-64.
2007: Komanduri Krishna V; St John Lisa S; de Lima Marcos; McMannis John; Rosinski Steven; McNiece Ian; Bryan Susan G; Kaur Indreshpal; Martin Sean; Wieder Eric D; Worth Laura; Cooper Laurence J N; Petropoulos Demetrios; Molldrem Jeffrey J; Champlin Richard E; Shpall Elizabeth J
Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing.
Blood 2007;110(13):4543-51.
2007: Oran B; Giralt S; Couriel D; Hosing C; Shpall E J; de Meis E; Khouri I F; Qazilbash M; Anderlini P; Kebriaei P; Popat U; Carrasco-Yalan A; Champlin R E; de Lima M
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(12):2540-4.
2007: Safdar Amar; Rodriguez Gilhen H; De Lima Marcos J; Petropoulos Demetrios; Chemaly Roy F; Worth Laura L; Shpall Elizabeth J; Rolston Kenneth V I; Raad Issam I; Chan Ka Wah; Champlin Richard E
Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005.
Medicine 2007;86(6):324-33.
2007: Nieto Yago; Nawaz Fatima; Jones Roy B; Shpall Elizabeth J; Nawaz Samia
Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4405-13.
2007: Patah P A; Parmar S; McMannis J; Sadeghi T; Karandish S; Rondon G; Tarrand J; Champlin R; de Lima M; Shpall E J
Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
Bone marrow transplantation 2007;40(4):365-8.
2007: Ballen Karen K; Shpall Elizabeth J; Avigan David; Yeap Beow Y; Fisher David C; McDermott Kathleen; Dey Bimalangshu R; Attar Eyal; McAfee Steven; Konopleva Marina; Antin Joseph H; Spitzer Thomas R
Phase I trial of parathyroid hormone to facilitate stem cell mobilization.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(7):838-43.
2007: Jabbour Elias; Cortes Jorge; Kantarjian Hagop; Giralt Sergio; Andersson Borje S; Giles Francis; Shpall Elizabeth; Kebriaei Partow; Champlin Richard; de Lima Marcos
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity.
Cancer 2007;110(2):340-4.
2007: Ozdemir E; Saliba R M; Champlin R E; Couriel D R; Giralt S A; de Lima M; Khouri I F; Hosing C; Kornblau S M; Anderlini P; Shpall E J; Qazilbash M H; Molldrem J J; Chemaly R F; Komanduri K V
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.
Bone marrow transplantation 2007;40(2):125-36.
2007: Oran Betul; Donato Michele; Aleman Ana; Hosing Chitra; Korbling Martin; Detry Michelle A; Wei Caimiao; Anderlini Paolo; Popat Uday; Shpall Elizabeth; Giralt Sergio; Champlin Richard E
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):469-77.
2007: Zhang Sui; Shpall Elizabeth; Willerson James T; Yeh Edward T H
Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction.
Circulation research 2007;100(5):693-702.
2007: Safdar A; Rodriguez G; Rolston K V I; O'Brien S; Khouri I F; Shpall E J; Keating M J; Kantarjian H M; Champlin R E; Raad I I; Kontoyiannis D P
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation.
Bone marrow transplantation 2007;39(3):157-64.
2007: Madden Timothy; de Lima Marcos; Thapar Neil; Nguyen John; Roberson Soonja; Couriel Daniel; Pierre Betty; Shpall Elizabeth J; Jones Roy B; Champlin Richard E; Andersson Borje S
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(1):56-64.
2006: Wang Siqing; Hong Sungyoul; Yang Jing; Qian Jianfei; Zhang Xiang; Shpall Elizabeth; Kwak Larry W; Yi Qing
Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells.
Blood 2006;108(13):4071-7.
2006: Lekakis L; Giralt S; Couriel D; Shpall E J; Hosing C; Khouri I F; Anderlini P; Korbling M; Martin T; Champlin R E; de Lima M
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
Bone marrow transplantation 2006;38(6):421-6.
2006: Safdar Amar; Rodriguez Gilhen H; Lichtiger Benjamin; Dickey Burton F; Kontoyiannis Dimitrios P; Freireich Emil J; Shpall Elizabeth J; Raad Issam I; Kantarjian Hagop M; Champlin Richard E
Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
Cancer 2006;106(12):2664-71.
2006: Hosing Chitra; Qazilbash Muzaffar H; Kebriaei Partow; Giralt Sergio; Davis Marilyn S; Popat Uday; Anderlini Paolo; Shpall Elizabeth J; McMannis John; Körbling Martin; Champlin Richard E
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.
British journal of haematology 2006;133(5):533-7.
2006: de Lima Marcos; Shpall Elizabeth
Strategies for widening the use of cord blood in hematopoietic stem cell transplantation.
Haematologica 2006;91(5):584-7.
2006: Decker William K; Xing Dongxia; Li Sufang; Robinson Simon N; Yang Hong; Yao Xin; Segall Harry; McMannis John D; Komanduri Krishna V; Champlin Richard E; Shpall Elizabeth J
Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.
Vaccine 2006;24(16):3203-16.
2006: Couriel Daniel R; Hosing Chitra; Saliba Rima; Shpall Elizabeth J; Anderlini Paolo; Rhodes Beverly; Smith Veronica; Khouri Issa; Giralt Sergio; de Lima Marcos; Hsu Yvonne; Ghosh Shubhra; Neumann Joyce; Andersson Borje; Qazilbash Muzzafar; Hymes Sharon; Kim Stella; Champlin Richard; Donato Michele
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.
Blood 2006;107(8):3074-80.
2006: Thall Peter F; Wooten Leiko H; Shpall Elizabeth J
A geometric approach to comparing treatments for rapidly fatal diseases.
Biometrics 2006;62(1):193-201.
2006: Yang H; Eaves C; de Lima M; Lee M S; Champlin R E; McMannis J D; Robinson S N; Niu T; Decker W K; Xing D; Ng J; Li S; Yao X; Eaves A C; Jones R; Andersson B S; Shpall E J
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
Bone marrow transplantation 2006;37(6):575-82.
2006: Nieto Yago; Patton Nigel; Hawkins Timothy; Spearing Ruth; Bearman Scott I; Jones Roy B; Shpall Elizabeth J; Rabinovitch Rachel; Zeng Chan; Barón Anna; McSweeney Peter A
Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):217-25.
2006: Vredenburgh James J; Coniglio David; Broadwater Gloria; Jones Roy B; Ross Maureen; Shpall Elizabeth J; Hussein Atif; Rizzieri David; Marks Larry B; Gilbert Colleen; Affronti Mary Lou; Moore Sarah; McDonald Carolyn; Petros William P; Peters William P
Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):195-203.
2006: Decker William K; Xing Dongxia; Shpall Elizabeth J
Dendritic cell immunotherapy for the treatment of neoplastic disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):113-25.
2006: Robinson S N; Ng J; Niu T; Yang H; McMannis J D; Karandish S; Kaur I; Fu P; Del Angel M; Messinger R; Flagge F; de Lima M; Decker W; Xing D; Champlin R; Shpall E J
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells.
Bone marrow transplantation 2006;37(4):359-66.
2006: Couriel Daniel; Hosing Chitra; Saliba Rima; Shpall Elizabeth J; Andelini Paolo; Popat Uday; Donato Michele; Champlin Richard
Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1 Suppl 2):37-40.
2006: Parmar S; Robinson S N; Komanduri K; St John L; Decker W; Xing D; Yang H; McMannis J; Champlin R; de Lima M; Molldrem J; Rieber A; Bonyhadi M; Berenson R; Shpall E J
Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.
Cytotherapy 2006;8(2):149-57.
2006: Xing D; Decker W K; Li S; Robinson S N; Yang H; Segal H; O'Connor S; Yao X; Komanduri K V; McMannis J D; Jones R B; de Lima M; Champlin R E; Shpall E J
AML-loaded DC generate Th1-type cellular immune responses in vitro.
Cytotherapy 2006;8(2):95-104.
2005: Peppercorn Jeffrey; Herndon James; Kornblith Alice B; Peters William; Ahles Tim; Vredenburgh James; Schwartz Gary; Shpall Elizabeth; Hurd David D; Holland Jimmie; Winer Eric
Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
Cancer 2005;104(8):1580-9.
2005: Gutman J A; Bearman S I; Nieto Y; Sweetenham J W; Jones R B; Shpall E J; Zeng C; Baron A; McSweeney P A
Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility study.
Bone marrow transplantation 2005;36(5):443-51.
2005: Rosinski S L; McNiece I K; Shpall E J; Clough N; Russell P; Blunk B; Nieto Y
Prognostic analysis of pre-transplant peripheral T-cell levels in patients receiving an autologous hematopoietic progenitor-cell transplant.
Bone marrow transplantation 2005;36(5):425-30.
2005: Nieto Yago; Shpall Elizabeth J; Bearman Scott I; Jones Roy B
Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapy.
American journal of clinical oncology 2005;28(3):248-54.
2005: Lazarus Hillard M; Koc Omer N; Devine Steven M; Curtin Peter; Maziarz Richard T; Holland H Kent; Shpall Elizabeth J; McCarthy Philip; Atkinson Kerry; Cooper Brenda W; Gerson Stanton L; Laughlin Mary J; Loberiza Fausto R; Moseley Annemarie B; Bacigalupo Andrea
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):389-98.
2005: Nieto Yago; Shpall Elizabeth J; Bearman Scott I; McSweeney Peter A; Cagnoni Pablo J; Matthes Steve; Gustafson Dan; Long Michael; Barón Anna E; Jones Roy B
Phase I and pharmacokinetic study of docetaxel combined with melphalan and carboplatin, with autologous hematopoietic progenitor cell support, in patients with advanced refractory malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):297-306.
2005: Khouri Issa F; Saliba Rima M; Hosing Chitra; Okoroji Grace-Julia; Acholonu Sandra; Anderlini Paolo; Couriel Daniel; De Lima Marcos; Donato Michele L; Fayad Luis; Giralt Segio; Jones Roy; Korbling Martin; Maadani Farzaneh; Manning John T; Pro Barbara; Shpall Elizabeth; Younes Anas; McLaughlin Peter; Champlin Richard E
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2240-7.
2005: Peters William P; Rosner Gary L; Vredenburgh James J; Shpall Elizabeth J; Crump Michael; Richardson Paul G; Schuster Michael W; Marks Lawrence B; Cirrincione Constance; Norton Larry; Henderson I C; Schilsky Richard L; Hurd David D
Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2191-200.
2005: Weinberg Adriana; Enomoto Laura; Li Shaobing; Shen Dingxia; Coll Joseph; Shpall Elizabeth J
Risk of transmission of herpesviruses through cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(1):35-8.
2005: Körbling M; Robinson S; Estrov Z; Champlin R; Shpall E
Umbilical cord blood-derived cells for tissue repair.
Cytotherapy 2005;7(3):258-61.
2005: Robinson S; Niu T; de Lima M; Ng J; Yang H; McMannis J; Karandish S; Sadeghi T; Fu P; del Angel M; O'Connor S; Champlin R; Shpall E
Ex vivo expansion of umbilical cord blood.
Cytotherapy 2005;7(3):243-50.
2004: Nieto Yago; Vredenburgh James J; Shpall Elizabeth J; Bearman Scott I; McSweeney Peter A; Chao Nelson; Rizzieri David; Gasparetto Christina; Matthes Steve; Barón Anna E; Jones Roy B
Phase II feasibility and pharmacokinetic study of concurrent administration of trastuzumab and high-dose chemotherapy in advanced HER2+ breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7136-43.
2004: Cheng Yee Chung; Rondón Gabriela; Yang Ying; Smith Terry L; Gajewski James L; Donato Michele L; Shpall Elizabeth J; Jones Roy; Hortobagyi Gabriel N; Champlin Richard E; Ueno Naoto T
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(11):794-804.
2004: Nieto Yago; Jones Roy B; Shpall Elizabeth J
Stem-cell transplantation for the treatment of advanced solid tumors.
Springer seminars in immunopathology 2004;26(1-2):31-56.
2004: Ueno Naoto T; Shpall Elizabeth J; Champlin Richard E; Jones Roy B
Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontier.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3846-7.
2004: Nieto Yago; Shpall Elizabeth J; McNiece Ian K; Nawaz Samia; Beaudet Julie; Rosinski Steve; Pellom Julie; Slat-Vasquez Victoria; McSweeney Peter A; Bearman Scott I; Murphy James; Jones Roy B
Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5076-86.
2004: de Lima Marcos; Couriel Daniel; Thall Peter F; Wang Xuemei; Madden Timothy; Jones Roy; Shpall Elizabeth J; Shahjahan Munir; Pierre Betty; Giralt Sergio; Korbling Martin; Russell James A; Champlin Richard E; Andersson Borje S
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.
Blood 2004;104(3):857-64.
2004: Stiff Patrick J; Shpall Elizabeth J; Liu P Y; Wilczynski Sharon P; Callander Natalie S; Scudder Sidney A; Jazieh Abdul-Rahman; Samlowski Wolfram; McCoy Jason; Alberts David S;
Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study.
Gynecologic oncology 2004;94(1):98-106.
2004: de Lima Marcos; Shpall Elizabeth J
Ex-vivo purging of hematopoietic progenitor cells.
Current hematology reports 2004;3(4):257-64.
2004: Nieto Yago; Franklin Wilbur A; Jones Roy B; Berman Scott I; Pellom Julie; Barón Anna E; Shpall Elizabeth J
Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(6):415-25.
2004: Nieto Yago; Nawaz Samia; Shpall Elizabeth J; Bearman Scott I; Murphy James; Jones Roy B
Long-term analysis and prospective validation of a prognostic model for patients with high-risk primary breast cancer receiving high-dose chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2609-17.
2004: Nieto Yago; Jones Roy B; Shpall Elizabeth J
High-dose chemotherapy for breast cancer: is another look warranted?
Current opinion in oncology 2004;16(2):114-9.
2003: Khorshid O; de Meis E; Martin T; Jones R B; Shpall E J; Nieto Y; Khouri I; Shahjahan M; Gajewski J; Giralt S; Champlin R; de Lima M
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(12):2538-40.
2003: Suratt Benjamin T; Cool Carlyne D; Serls Amanda E; Chen Lin; Varella-Garcia Marileila; Shpall Elizabeth J; Brown Kevin K; Worthen G Scott
Human pulmonary chimerism after hematopoietic stem cell transplantation.
American journal of respiratory and critical care medicine 2003;168(3):318-22.
2003: Medeiros B C; Kolhouse J F; Cagnoni P J; Ryder J; Nieto Y; Rabinovitch R; Shpall E J; Bearman S I; Jones R B; McSweeney P A
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia.
Bone marrow transplantation 2003;31(11):1053-5.
2002: Parikh Chirag R; McSweeney Peter A; Korular Didem; Ecder Tevfik; Merouani Aicha; Taylor Jeremy; Slat-Vasquez Vicki; Shpall Elizabeth J; Jones Roy B; Bearman Scott I; Schrier Robert W
Renal dysfunction in allogeneic hematopoietic cell transplantation.
Kidney international 2002;62(2):566-73.
2002: McNiece Ian K; Almeida-Porada Graça; Shpall Elizabeth J; Zanjani Esmail
Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential.
Experimental hematology 2002;30(6):612-6.
2002: Nieto Yago; Nawaz Samia; Jones Roy B; Shpall Elizabeth J; Cagnoni Pablo J; McSweeney Peter A; Barón Anna; Razook Carrington; Matthes Steve; Bearman Scott I
Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):707-18.
2002: Hogan Christopher J; Shpall Elizabeth J; Keller Gordon
Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(1):413-8.
2002: Shpall Elizabeth J; Quinones Ralph; Giller Roger; Zeng Chan; Baron Anna E; Jones Roy B; Bearman Scott I; Nieto Yago; Freed Brian; Madinger Nancy; Hogan Christopher J; Slat-Vasquez Vicki; Russell Peggy; Blunk Betsy; Schissel Deborah; Hild Elaine; Malcolm Janet; Ward William; McNiece Ian K
Transplantation of ex vivo expanded cord blood.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):368-76.
2001: Nieto Y; Bearman S I; Shpall E J; Jones R B; Cagnoni P J; Rabinovitch R A; McSweeney P A
Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograft.
Bone marrow transplantation 2001;28(11):1083-6.
2000: Howrey R P; Martin P L; Driscoll T; Szabolcs P; Kelly T; Shpall E J; Bearman S I; Slat-Vasquez V; Rubinstein P; Stevens C E; Kurtzberg J
Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia.
Bone marrow transplantation 2000;26(11):1251-4.
2000: McNiece I; Jones R; Bearman S I; Cagnoni P; Nieto Y; Franklin W; Ryder J; Steele A; Stoltz J; Russell P; McDermitt J; Hogan C; Murphy J; Shpall E J
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer.
Blood 2000;96(9):3001-7.
2000: McNiece I; Kubegov D; Kerzic P; Shpall E J; Gross S
Increased expansion and differentiation of cord blood products using a two-step expansion culture.
Experimental hematology 2000;28(10):1181-6.
2000: Nieto Y; Russ P; Everson G; Bearman S I; Cagnoni P J; Jones R B; Shpall E J
Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation.
Bone marrow transplantation 2000;26(1):109-11.
2000: Nieto Y; Cagnoni P J; Nawaz S; Shpall E J; Yerushalmi R; Cook B; Russell P; McDermit J; Murphy J; Bearman S I; Jones R B
Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(10):2070-80.
2000: Nieto Y; Shpall E J
High-dose chemotherapy for breast cancer.
Cancer treatment and research 2000;103():77-114.
2000: Nieto Y; Cagnoni P J; Bearman S I; Shpall E J; Matthes S; Jones R B
Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(2A):198-203.
1999: Nieto Y; Cagnoni P J; Shpall E J; Xu X; Murphy J; Vredenburgh J; Chao N J; Bearman S I; Jones R B
A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3425-31.
1999: Nieto Y; Shpall E J
Autologous stem-cell transplantation for solid tumors in adults.
Hematology/oncology clinics of North America 1999;13(5):939-68, vi.
1999: Johnson D W; Cagnoni P J; Schossau T M; Stemmer S M; Grayeb D E; Baron A E; Shpall E J; Bearman S I; McDermitt J; Jones R B
Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support.
Bone marrow transplantation 1999;24(7):785-92.
1999: Rizzieri D A; Vredenburgh J J; Jones R; Ross M; Shpall E J; Hussein A; Broadwater G; Berry D; Petros W P; Gilbert C; Affronti M L; Coniglio D; Rubin P; Elkordy M; Long G D; Chao N J; Peters W P
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3064-74.
1999: Bearman S; Vredenburgh J; Cagnoni P; Shpall E; Nieto Y; Ross M; Peters W; Jones R
High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy.
Bone marrow transplantation 1999;24(5):491-5.
1999: Cagnoni P J; Matthes S; Day T C; Bearman S I; Shpall E J; Jones R B
Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics.
Bone marrow transplantation 1999;24(1):1-4.
1999: Nieto Y; Cagnoni P J; Shpall E J; Matthes S; Barón A; Jones R B; Bearman S I
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1731-7.
1999: Franklin W A; Glaspy J; Pflaumer S M; Jones R B; Hami L; Martinez C; Murphy J R; Shpall E J
Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone.
Blood 1999;94(1):340-7.
1999: Nieto Y; Ross M; Gianani R; Shpall E J; Cagnoni P J; Bearman S I; Jones R B
Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant.
Bone marrow transplantation 1999;23(12):1323-4.
1999: McNiece I; Jones R; Cagnoni P; Bearman S; Nieto Y; Shpall E J
Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer.
Hematology and cell therapy 1999;41(2):82-6.
1999: Nieto Y; Xu X; Cagnoni P J; Matthes S; Shpall E J; Bearman S I; Murphy J; Jones R B
Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(4):747-51.
1999: Shpall E J; Wheeler C A; Turner S A; Yanovich S; Brown R A; Pecora A L; Shea T C; Mangan K F; Williams S F; LeMaistre C F; Long G D; Jones R; Davis M W; Murphy-Filkins R; Parker W R; Glaspy J A
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.
Blood 1999;93(8):2491-501.
1999: Shpall E J; Jones R B; Bearman S I; Cagnoni P J; Nieto Y; McNiece I K
Peripheral blood stem cell transplantation in breast cancer.
Baillière's best practice & research. Clinical haematology 1999;12(1-2):219-32.
1999: Nieto Y; Cagnoni P J; Bearman S I; Shpall E J; Matthes S; DeBoom T; Barón A; Jones R B
Acute encephalopathy: a new toxicity associated with high-dose paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(3):501-6.
1999: Banda N K; Simon G R; Sipple J D; Terrell K L; Archer P; Shpall E J; Akkina R K; Myers A M; Harrison G S
Depletion of CD34+ CD4+ cells in bone marrow from HIV-1-infected individuals.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(3):162-72.
1998: Banda N K; Akkina R K; Terrell K; Shpall E J; Tomczak J; Campain J; Claman H; Cagle L; Harrison G S
Diphtheria toxin A gene-mediated HIV-1 protection of cord blood-derived T cells in the SCID-hu mouse model.
Journal of hematotherapy 1998;7(4):319-31.
1998: Cagnoni P J; Nieto Y; Shpall E J; Bearman S I; Barón A E; Ross M; Matthes S; Dunbar S E; Jones R B
High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1661-8.
1998: Pugh R E; Bitter M A; Shpall E J; Hami L S; Wolf D M; Franklin W A
CD19 selection improves the sensitivity of B cell lymphoma detection.
Journal of hematotherapy 1998;7(2):159-68.
1998: Hayward A; Ambruso D; Battaglia F; Donlon T; Eddelman K; Giller R; Hobbins J; Hsia Y E; Quinones R; Shpall E; Trachtenberg E; Giardina P
Microchimerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1.
Fetal diagnosis and therapy 1998;13(1):8-14.
1998: Shpall E J; Champlin R; Glaspy J A
Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(2):84-92.
1998: Nieto Y; Cagnoni P J; Shpall E J
High-dose chemotherapy in gynecologic malignancies.
Cancer treatment and research 1998;95():277-85.
1997: Bearman S I; Overmoyer B A; Bolwell B J; Taylor C W; Shpall E J; Cagnoni P J; Mechling B E; Ronk B; Barón A E; Purdy M H; Ross M; Jones R B
High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes.
Bone marrow transplantation 1997;20(11):931-7.
1997: Shpall E J; LeMaistre C F; Holland K; Ball E; Jones R B; Saral R; Jacobs C; Heimfeld S; Berenson R; Champlin R
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy.
Blood 1997;90(11):4313-20.
1997: Campain J A; Terrell K L; Tomczak J A; Shpall E J; Hami L S; Harrison G S
Comparison of retroviral-mediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):273-81.
1997: Hogan C J; Shpall E J; McNiece I; Keller G
Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):236-46.
1997: Glaspy J A; Shpall E J; LeMaistre C F; Briddell R A; Menchaca D M; Turner S A; Lill M; Chap L; Jones R; Wiers M D; Sheridan W P; McNiece I K
Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.
Blood 1997;90(8):2939-51.
1997: Gehling U M; Ryder J W; Hogan C J; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall E J
Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Experimental hematology 1997;25(11):1125-39.
1997: Shpall E J
Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors.
Journal of hematotherapy 1997;6(4):287-9.
1997: Hogan C J; Shpall E J; McNulty O; McNiece I; Dick J E; Shultz L D; Keller G
Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice.
Blood 1997;90(1):85-96.
1997: Cagnoni P J; Shpall E J
High-dose chemotherapy for the treatment of breast and ovarian cancer.
Current opinion in oncology 1997;9(2):122-5.
1997: Banda N K; Tomczak J A; Shpall E J; Sipple J; Akkina R K; Steimer K S; Hami L; Curiel T J; Singer Harrison G
HIV-gp120 induced cell death in hematopoietic progenitor CD34+ cells.
Apoptosis : an international journal on programmed cell death 1997;2(1):61-8.
1997: Shpall E J; Cagnoni P J; Bearman S I; Ross M; Nieto Y; Jones R B
Peripheral blood stem cell harvesting and CD34-positive cell selection.
Cancer treatment and research 1997;77():143-57.
1997: Shpall E J; Cagnoni P J; Bearman S I; Ross M; Jones R B
Peripheral blood stem cells for autografting.
Annual review of medicine 1997;48():241-51.
1996: Cagnoni P J; Shpall E J; Bearman S I; Matthes S; Ross M; Taffs S; Jones R B
Paclitaxel-containing high-dose chemotherapy: the University of Colorado experience.
Seminars in oncology 1996;23(6 Suppl 15):43-8.
1996: Cagnoni P J; Shpall E J; Bearman S I; Ross M; Jones R B
High-dose chemotherapy with AHPCS for the treatment of breast cancer. The University of Colorado results.
Bone marrow transplantation 1996;18 Suppl 1():S26-9.
1996: Merouani A; Shpall E J; Jones R B; Archer P G; Schrier R W
Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer.
Kidney international 1996;50(3):1026-31.
1996: Cagnoni P J; Jones R B; Bearman S I; Ross M; Hami L; Franklin W A; Capizzi R; Schein P S; Shpall E J
Use of amifostine in bone marrow purging.
Seminars in oncology 1996;23(4 Suppl 8):44-8.
1996: Stemmer S M; Cagnoni P J; Shpall E J; Bearman S I; Matthes S; Dufton C; Day T; Taffs S; Hami L; Martinez C; Purdy M H; Arron J; Jones R B
High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: a phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1463-72.
1996: Shpall E J; Gee A P; Hogan C; Cagnoni P; Gehling U; Hami L; Franklin W; Bearman S I; Ross M; Jones R B
Bone marrow metastases.
Hematology/oncology clinics of North America 1996;10(2):321-43.
1996: Cagnoni P J; Shpall E J
Mobilization and selection of CD34-positive hematopoietic progenitors.
Blood reviews 1996;10(1):1-7.
1996: Bearman S I; Shpall E J; Jones R B; Cagnoni P J; Ross M
High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer.
Seminars in oncology 1996;23(1 Suppl 2):60-7.
1996: Berenson R J; Shpall E J; Auditore-Hargreaves K; Heimfeld S; Jacobs C; Krieger M S
Transplantation of CD34+ hematopoietic progenitor cells.
Cancer investigation 1996;14(6):589-96.
1996: Franklin W A; Shpall E J; Archer P; Johnston C S; Garza-Williams S; Hami L; Bitter M A; Bast R C; Jones R B
Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.
Breast cancer research and treatment 1996;41(1):1-13.
1995: Shpall E J; Gee A; Cagnoni P J; Hogan C; Gehling U; Hami L; Franklin W; Bearman S I; Ross M; Jones R B
Stem cell isolation.
Current opinion in hematology 1995;2(6):452-9.
1995: Harrison G S; Wang Y; Tomczak J; Hogan C; Shpall E J; Curiel T J; Felgner P L
Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells.
BioTechniques 1995;19(5):816-23.
1994: Shpall E J; Gehling U; Cagnoni P; Purdy M; Hami L; Gee A P
Isolation of CD34-positive hematopoietic progenitor cells.
ImmunoMethods 1994;5(3):197-203.
1994: Bitter M A; Fiorito D; Corkill M E; Huffer W E; Stemmer S M; Shpall E J; Archer P G; Franklin W A
Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histological examination alone.
Human pathology 1994;25(8):781-8.
1994: Shpall E J; Stemmer S M; Hami L; Franklin W A; Shaw L; Bonner H S; Bearman S I; Peters W P; Bast R C; McCulloch W
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support.
Blood 1994;83(11):3132-7.
1994: Shpall E J; Jones R B; Bearman S I; Franklin W A; Archer P G; Curiel T; Bitter M; Claman H N; Stemmer S M; Purdy M
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):28-36.
1994: Petsche D; Hami L; Purdy M; Myers S; Hogan C; Messner H; Briddell R; Heimfeld S; Berenson R; Shpall E
Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractions.
Progress in clinical and biological research 1994;389():415-20.
1994: Shpall E J; Jones R B; Bearman S I; Purdy M H; Franklin W A; Heimfeld S; Berenson R J
Transplantation of CD34+ hematopoietic progenitor cells.
Journal of hematotherapy 1994;3(2):145-7.
1993: Shpall E J; Jones R B; Bearman S I; Stemmer S M; Purdy M H; Heimfeld S; Berenson R J
Positive selection of CD34+ hematopoietic progenitor cells for transplantation.
Stem cells (Dayton, Ohio) 1993;11 Suppl 3():48-9.
1993: Shpall E J; Stemmer S M; Bearman S I; Jones R B
Role of autotransplantation in treatment of other solid tumors.
Hematology/oncology clinics of North America 1993;7(3):663-86.
1993: Jones R B; Matthes S; Shpall E J; Fisher J H; Stemmer S M; Dufton C; Stephens J K; Bearman S I
Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine.
Journal of the National Cancer Institute 1993;85(8):640-7.
1993: Jones R B; Matthes S; Dufton C; Bearman S I; Stemmer S M; Meyers S; Shpall E J
Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer.
Breast cancer research and treatment 1993;26 Suppl():S11-7.
1993: Shpall E J; Stemmer S M; Bearman S I; Myers S; Purdy M; Jones R B
New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation.
Breast cancer research and treatment 1993;26 Suppl():S19-23.
1992: Johnston C S; Shpall E J; Williams S; Hami L; Jones R B; Bast R C; Ceriani R L; Franklin W
Detection of minimal residual breast cancer in bone marrow.
Progress in clinical and biological research 1992;377():637-42.
1992: Shpall E J; Stemmer S M; Johnston C F; Hami L; Bearman S I; Berenson R; Jones R B
Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell.
Journal of hematotherapy 1992;1(1):45-54.
1992: Hami L S; Shpall E J; Johnston C S; Berenson R; Jones R B
The effect of PIXY-321 on 4-hydroperoxycyclophosphamide purged and CD34+ positively selected bone marrow.
Progress in clinical and biological research 1992;377():321-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Elizabeth Shpall

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Elizabeth Shpall (preview)

All Publications